Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kavya Pinto"'
Publikováno v:
International Journal of Noncommunicable Diseases, Vol 7, Iss 1, Pp 36-41 (2022)
Background: Type 2 diabetes contributes to significant productivity losses in paid work and unpaid work. Patients with Type 2 diabetes also feel distressed due to the concerns about disease management, its emotional burden, physician-related issues,
Externí odkaz:
https://doaj.org/article/cf642f7453bb4ce4a47353d4dd8653f5
Autor:
Himisha Beltran, Jaspreet S. Batra, Yuliya Jhanwar, Beerinder S. Karir, David M. Nanus, Linda Lam, Scott T. Tagawa, Shankar Vallabhajosula, Kavya Pinto-Chengot, Ana M. Molina, Gillian Hodes, Stanley J. Goldsmith, Paul J. Christos, Neil H. Bander
Publikováno v:
Journal of Urology. 195
Autor:
Jaspreet S. Batra, Kavya Pinto-Chengot, Himisha Beltran, Beerinder S. Karir, Paul J. Christos, Yuliya Jhanwar, Stanley J. Goldsmith, David M. Nanus, Neil H. Bander, Shankar Vallabhajosula, Scott T. Tagawa, Ana M. Molina
Publikováno v:
Cancer Research. 76:3971-3971
Background: PSMA is nearly universally expressed by PC, has a correlation with androgen receptor (AR) pathway dysregulation, and some studies have pointed towards PSMA expression as a prognostic marker. Non-invasive measurement of PSMA expression may
Autor:
Shankar Vallabhajosula, Beerinder S. Karir, Yuliya Jhanwar, Linda Lam, David M. Nanus, Scott T. Tagawa, Himisha Beltran, Kavya Pinto-Chengot, Gillian Hodes, Ana M. Molina, Jaspreet S. Batra, Paul J. Christos, Neil H. Bander, Stanley J. Goldsmith
Publikováno v:
Journal of Clinical Oncology. 34:205-205
205 Background: Phase I and II single dose 177Lu−J591 studies have been published. Based on the theoretical advantages of dose fractionation on safety and efficacy, we initiated a phase I dose−escalation study of fractionated−dose 177Lu−J591.
Autor:
Panagiotis J. Vlachostergios, Beerinder S. Karir, Himisha Beltran, Scott T. Tagawa, Victor Ra Febles, Ana M. Molina, Paul J. Christos, Kavya Pinto-Chengot, David M. Nanus
Publikováno v:
Journal of Clinical Oncology. 34:268-268
268 Background: Various clinical and pathologic criteria have been proposed to identify neuroendocrine (NE) or aggressive variant (AV) prostate cancer (PC). We assessed the prognostic value of clinical parameters in a single-institution cohort. Metho
Autor:
David C. Zawieja, Moheb Boktor, Pierre-Yves von der Weid, Paul Jordan, Mahmoud Al-Kofahi, Judith L. Palmer Castor, Kavya Pinto, Felix Becker, Dmitry V. Ostanin, Yuping Wang, Matthew D. Woolard, Ikuo Tsunoda, Mariappan Muthuchamy, Ankur Sheth
Publikováno v:
Gastroenterology. 146:S-830